More on AARD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.86 |
|
|||
| Open | $4.19 | ||||
| 52 Wk High | $0.45 | ||||
| 52 Wk Low | $0.35 | ||||
| Day High | $4.19 | ||||
| Day Low | $3.73 | ||||
| P/E | N/A | ||||
| EPS | $-0.27 | ||||
| Volume | 97,165 | ||||
- Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and Power Solutions International, Inc. (NASDA
- Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and The Simply Goo
- Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG): Graba
- Form 4 Aardvark Therapeutics, For: Oct 07 Filed by: Zhang Zhongwei
- Form 3 Aardvark Therapeutics, For: Oct 07 Filed by: Zhang Zhongwei
- Form 8-K Aardvark Therapeutics, For: Oct 06
- Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and New Era Energy & Digital, Inc. (NASDAQ: NU
- Aardvark Therapeutics adds David Zhang to its board
- Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
- Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The
Entities mentioned with AARD
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- IPO | View Related Stories »
- Definitive Agreement | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
